Ligand validation:9NDU

HLZ: 1-hydrazinophthalazine

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9NDU_HLZ_A_306	46%	18%	0.099	0.829	1.88	1.54	3	2	0	0	100%	1
9NDU_HLZ_B_303	43%	53%	0.124	0.846	0.73	0.93	-	1	1	0	100%	1
9NDU_HLZ_A_302	26%	49%	0.141	0.785	0.76	1.09	-	1	0	0	100%	1
9NDU_HLZ_B_302	22%	53%	0.154	0.775	0.69	0.98	-	-	2	0	100%	1
9DMA_HLZ_A_302	83%	39%	0.08	0.941	0.96	1.33	-	1	0	0	100%	1
9DY4_HLZ_A_302	48%	50%	0.107	0.845	0.73	1.08	-	1	0	0	100%	1
3LTW_HLZ_A_300	16%	15%	0.217	0.796	2.31	1.4	3	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.